Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
Une IA expérimentale d’OpenAI cherche à rajeunir vos cellules et créer des organes sur mesure https://t.co/To0cwVWC3Z
It’s an incredible time in biomedicine. We’re applying advances in large language models to accelerate research. We recently shared initial cell models that will help researchers discover the cellular basis of health & disease, with lots more to come https://t.co/1IInT7ly8R
To understand the scale of impact AI will have, it’s not only chatbots and writing tools but also being used to accelerate scientific discovery — from protein folding to drug discovery to understanding biology on whole new levels. https://t.co/Lhecxxeg00
OpenAI is advancing longevity science through its latest AI model, which reportedly enhances cellular reprogramming by proposing modifications to Yamanaka factors in collaboration with Retro Bio. The model, referred to as GPT-4b, is designed to assist in drug discovery and the creation of proteins that can rejuvenate normal cells into stem cells. This initiative marks a significant step in the application of AI in scientific discovery, with implications for extending life expectancy. Notable organizations, including Google DeepMind and the Chan Zuckerberg Initiative, are also leveraging large language models to accelerate biomedical research, focusing on the cellular basis of health and disease.
